Regorafenib (brand name Stivarga) is an oral multi-kinase inhibitor used mainly to treat certain cancers, including colorectal cancer, liver cancer (hepatocellular carcinoma, HCC) and gastrointestinal stromal tumors (GISTs). It works by targeting several tyrosine kinases involved in tumor growth, angiogenesis (blood vessel formation) and cancer cell survival and Regorafenib Price in Philippines.
1. Effectiveness in colorectal cancer (CRC)
Regorafenib is used for metastatic colorectal cancer (mCRC), especially in patients whose canc...
more